Think OTC derivatives regulation and you’re likely to think standardisation, the disappearance of many hundreds of jobs structuring and selling bespoke derivative products, and the probable demise of at least some of the people currently engrossed with filling out derivatives documentation once all or most OTC products are centrally cleared on exchanges.

Financial News has, however, unearthed at least one company that plans to add rather than remove staff due to the new regulations.

Newedge, the multi-asset brokerage firm forged from a joint venture between Société Générale and Crédit Agricole, says it wants to hire 250 people between now and 2012 in preparation for parts of the OTC market moving onto exchanges.

Newedge is particularly excited about the prospects for exchange trading parts of the enormous $426 trillion interest rate swaps market.

A glance at Newedge’s website suggests it’s currently hiring 57 people, although only five of them are being sought in London.

A French spokesman for the company told us the new hires will be ‘mondial,’ and that they’ll mostly be in the front office, although he declined to say what they’ll be doing exactly. It’s still early days: “It’s a figure we’re aiming for. There’s no exact plan at this stage,” he added.

Newedge’s new jobs may prove the exception rather than the rule, however. Patrick Clancy, partner and head of UK derivatives at Shearman & Sterling, thinks standardisation will lead to fewer jobs overall. Ralph Silva, an analyst at TowerGroup thinks so too: “This isn’t actually creating jobs, it’s just replacing some of the jobs we’re going to lose,” says Silva.